Results 101 to 110 of about 897,555 (284)

Multidrug-resistant Acinetobacter meningitis in children

Journal of Family Medicine and Primary Care, 2016
Acinetobacter species have emerged as one of the most troublesome pathogens for healthcare institutions globally. In more recent times, nosocomial infections involving the central nervous system, skin and soft tissue, and bone have emerged as highly ...
Ira Shah, Muznah Kapdi
doaj   +1 more source

Efficacy of Cefoperazone Sulbactam in Patients with Acinetobacter Infections: A Systematic Review of the Literature. [PDF]

Antibiotics (Basel), 2023
Kogilathota Jagirdhar GS, Rama K, Reddy ST, Pattnaik H, Qasba RK, Elmati PR, Kashyap R, Schito M, Gupta N, Gupta N.   +9 more
europepmc   +1 more source

A structured multidisciplinary home parenteral nutrition program in a public healthcare system: Implementation model, nursing‐led training protocol, and 11‐year safety outcomes

Nutrition in Clinical Practice, EarlyView.
Abstract Background Home parenteral nutrition (HPN) is the standard of care for adults with chronic intestinal failure (CIF), but evidence from publicly funded healthcare systems in middle‐income countries is limited. This study describes an 11‐year experience of a structured, nursing‐led HPN program within Brazil's Unified Health System (SUS ...
Tatiana da Cunha Rana, Mariana Hollanda Martins da Rocha, Luiz Augusto Carneiro d'Albuquerque, André Dong Won Lee, Wellington Andraus, Luciana Bertocco de Paiva Haddad   +5 more
wiley   +1 more source

Carbapenem-resistant Acinetobacter [PDF]

cdc:82532Type: BacteriaAbout: Carbapenem-resistant Acinetobacter cause pneumonia and wound, bloodstream, and urinary tract infections. Nearly all these infections happen in patients who recently received care in a healthcare facility.Estimated cases in ...

core  

A Multicenter Study of Risk Factors and Outcome of Hospitalized Patients with Infections Due to Carbapenem-Resistant Acinetobacter Baumannii

, 2011
Risk factors and outcome in patients who acquire nosocomial infections due to carbapenem-resistant Acinetobacter baumannii (CRAB) are rarely investigated.
SHENG, WANG-HUEI;LIAO, CHUN-HSIN;YANG, LAUDERDALE TSAI-LING;KO, WEN-CHIEN;CHEN, YAO-SHEN;LIU, JIEN-WEI;LAU, YEU-JUN;LIU, KE-SUN;HSU, MENG- SHIUAN;CHANG, SHAN-CHWEN, 盛望徽;廖俊星;楊采菱;柯文謙;陳垚生;劉建衛;劉有增;劉克森;許孟璇;張上淳   +1 more
core   +1 more source

Uptake, metabolism, and bioremediation of neonicotinoid insecticides in soil–plant systems: A review

New Plant Protection, EarlyView.
This review summarizes the uptake and metabolic transformation of neonicotinoid insecticides in plants, showing that some metabolites exhibit higher toxicity. We also critically assess promising bioremediation strategies using microbes and plant–microbe interactions to reduce residue contamination.
Wenwen Guo, Jiayue Liu, Yichen Yang, Hui Li, Runan Li, Yuanbo Li   +5 more
wiley   +1 more source

Analysis of Acinetobacter baumannii hospital infections in patients treated at the intensive care unit of the University Hospital, Wroclaw, Poland: a 6-year, single-center, retrospective study

, 2018
Wieslawa Duszynska,1 Agnieszka Litwin,2 Stanislaw Rojek,1 Aleksander Szczesny,3 Alfonso Ciasullo,1 Waldemar Gozdzik1 1Department of Anesthesiology and Intensive Therapy, Wroclaw Medical University, Wroclaw, Poland; 2Microbiology Laboratory, Wroclaw ...
Szczesny A, Gozdzik W, Ciasullo A, Duszynska W, Rojek S, Litwin A   +5 more
core  

Evaluation of the Antimicrobial Ability of Probiotics Against Nosocomial Infections by Inhibiting Ompa Gene Expression in Acinetobacter Baumannii

Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk, 2021
Background: and Aim Acinetobacter baumannii causes various nosocomial infections and has a high antibiotic resistance. Probiotics can produce metabolites with antimicrobial properties.
Farangis Ghanipour, Razieh Nazari, Seyed Soheil Aghaee, Parvane Jafari   +3 more
doaj  

Ruta graveolens L. in Evidence‐Based Phytotherapy: Pharmacological Activities, Bioactive Compounds and Safety

Phytotherapy Research, EarlyView.
Graphical representation of ethnomedical uses, major bioactive compounds, pharmacological potential and toxicological risks of Ruta graveolens L. ABSTRACT Ruta graveolens L. is widely used in traditional European, Asian, African, and South American medicine for digestive, nervous, cardiovascular, respiratory, and reproductive disorders.
Tetiana Serhiienko, Victoriya Georgiyants, Liudas Ivanauskas, Olha Mykhailenko   +3 more
wiley   +1 more source

Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam. [PDF]

Front Microbiol, 2021
Shapiro AB, Moussa SH, McLeod SM, Durand-Réville T, Miller AA.   +4 more
europepmc   +1 more source